Investing

Cardiff Oncology : CRDF

CRDF

Stock Data

$1.71

$0.02 (1.16%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops drugs for the treatment of cancer. The company is headquartered in San Diego, California.

All Cardiff Oncology Articles

1 Article

Jon C. Ogg | Sep 29, 2020 at 5:35 PM EDT

6 Secondary Offerings Making Big Moves in Stocks

24/7 Wall St. tracked six new secondary offerings that were announced after the close on Tuesday, September 29, 2020.